Boosting Vaccine Production Needs the Right Degree of Flexibility
The pandemic has seen an unprecedented global effort to accelerate the development of safe and effective vaccines as well as a rapid expansion of vaccine manufacturing capacity.
The pandemic has seen an unprecedented global effort to accelerate the development of safe and effective vaccines as well as a rapid expansion of vaccine manufacturing capacity.
Simulation technology is continually advancing to model increasingly real-world product behavior; however, many companies lag in its adoption.
The RoboCrane—now hard at work at the Chernobyl and Fukushima nuclear cleanup sites—is a good example of a successfully commercialized technology invented at the National Institute of Standards and Technology (NIST). I’ll try to tell that story here.
For medical device manufacturers, finding success means setting ourselves up for success with repeatable processes that not only ensure quality but also mitigate future risk.
Risks are inherent in the construction industry, and they come in various types.
In 1996, the TSSC (Toyota Production System Support Center) began working with my company to create one-by-one production capability in our product assembly.
It’s a great feeling for business leaders when they find a framework they know can change the way their company formulates and executes their goals.
Finding good employees has always been a challenge, but these days it’s harder than ever. And it’s unlikely to improve anytime soon.
The origin of SARS-CoV-2 remains a mystery.
There are many endangered industries today, and publishing is certainly among them.
© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.